Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.5B | 7.2B | 8.0B | 7.6B |
Cost of revenue | 7.4B | 6.2B | 6.8B | 6.7B |
Gross profit | 110M | 953M | 1.2B | 872M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 348M | 315M | 377M | 394M |
Other operating expenses | — | — | — | — |
Operating income | -122M | -171M | 833M | 478M |
Non operating interest income | ||||
Income | 17M | -38M | 13M | 4M |
Expense | 202M | 175M | 205M | 206M |
Other income expense | — | — | — | — |
Pretax income | -302M | -231M | 593M | 317M |
Tax provision | 26M | 39M | 22M | 29M |
Net income | -328M | -270M | 571M | 288M |
Basic EPS | -6.1 | — | 10.4 | 5.2 |
Diluted EPS | -6.1 | — | 10.4 | 5.1 |
Basic average shares | 54.0M | — | 54.9M | 55.5M |
Diluted average shares | 54.0M | — | 54.9M | 55.8M |
EBITDA | -107M | -229M | 844M | 481M |
Net income from continuing op. | 748M | 743M | 1.5B | 1.2B |
Minority interests | -1M | 0 | -1M | -2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |